CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis

Figure 3

Survival analyses of COAD cohort from our hospital. The overall survival curve of entire COAD cohort was plotted using Kaplan–Meier method (a) In addition, survival curves were compared in different sub-groups divided based on patients’ age (b), sex (c), tumor location (d), tumor size (e), T stage (f), lymph node metastasis (g), chemotherapy (h), and CSRP1 protein level (i)

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)